Fundz

Plasmagen Biosciences Raises Rs 225 Crore In Equity Funding

Dec 14, 2023

Amount Raised

₹2.25 Billion

Round Type

Venture

ManufacturingBiotechnologyPharmaceutical Manufacturingpharmaceuticals

Description

Biopharmaceutical company PlasmaGen Biosciences has raised Rs 225 crore (roughly $27 million) in equity funding from UK-based investment management firm Artian Investments, Ashish Rameshchandra Kacholia and other high-net-worth individuals (HNIs). Kacholia is known to pick up stakes in companies and invest in public markets.

Quick answer

PlasmaGen Biosciences raised ₹2.25 Billion in a funding round, dated December 14, 2023.

How much did PlasmaGen Biosciences raise?
PlasmaGen Biosciences raised ₹2.25 Billion in a funding round on December 14, 2023.
What does PlasmaGen Biosciences do?
PlasmaGen BioSciences Private Limited is India’s first company dedicated to Plasma Protein Therapeutics, founded in 2010 and headquartered in Bengaluru.
Where is PlasmaGen Biosciences based and how big is it?
Fundz records about 420 employees.
Who are the decision-makers at PlasmaGen Biosciences?
Fundz holds 1 contact at PlasmaGen Biosciences. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Pharmaceutical Manufacturing and pharmaceuticals around the same time

Companies in the same sectors as PlasmaGen Biosciences that raised within 45 days of this round, from Fundz verified event records.

  • RedHill Biopharma Ltd raised $10M on January 25, 2024.
  • icotec ag raised $30M (Funding Round) on January 25, 2024.
  • icotec ag raised $30M (Funding Round) on January 24, 2024.
  • 3Daughters raised $2M (Seed) on January 22, 2024.
  • Allarity Therapeutics raised $400K (Seed) on January 18, 2024.
  • Lynch Regenerative Medicine raised $3.8M (Seed) on January 17, 2024.

Who to call at PlasmaGen Biosciences, and when

A new round usually means PlasmaGen Biosciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day PlasmaGen Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at PlasmaGen Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at PlasmaGen Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

PlasmaGen Biosciences

Location

160 5th Main Road

About

PlasmaGen BioSciences Private Limited is India’s first company dedicated to Plasma Protein Therapeutics, founded in 2010 and headquartered in Bengaluru. Established to address the critical gap between the demand and supply of plasma protein products, PlasmaGen is committed to improving patient health and quality of life across India. The company also drives nationwide awareness on plasma utilization and rare diseases such as Hemophilia, Thalassemia, and Primary Immunodeficiencies. With its upcoming manufacturing facility in Kolar, PlasmaGen is advancing India’s goal of self-sufficiency in plasma-derived medicinal products while promoting innovation, awareness, and national health resilience.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment PlasmaGen Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for PlasmaGen Biosciences's next move

See what Strategic adds

PlasmaGen Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.